The relationship between lung cancer histology and the clinicopathological characteristics of bone metastases
- PMID: 27133744
- DOI: 10.1016/j.lungcan.2016.03.014
The relationship between lung cancer histology and the clinicopathological characteristics of bone metastases
Abstract
Objectives: Lung cancer is the leading cause of death due to cancer, and bone is one of the most frequent sites of metastasis. However, there is no published evidence regarding an association between lung cancer histology and skeletal complications. Therefore, we evaluated the influence of lung cancer histology on the frequency of bone metastases (BMs), skeletal-related events (SREs), and survival after BM.
Material and methods: This retrospective study evaluated medical records from 413 patients who were diagnosed with lung cancer between 2003 and 2012. The prevalences of BMs and SREs were calculated, and their associations with the histological subtypes were evaluated using the chi-square test, odds ratios (OR), and 95% confidence intervals (CI). Overall survivals and associations with the histological subtypes were evaluated using the Kaplan-Meier method and the log-rank test.
Results: The prevalences of BM, synchronous BM, and SREs were 28.2%, 70.4%, and 68.7%, respectively. Adenocarcinoma was the most common histological subtype (46.7%), and was significantly more frequent among patients with BM (58.3% vs. 42.1%; p=0.003; OR: 1.92; 95% CI: 1.29-2.97). Squamous cell was significantly less frequent among patients with BM (13.0% vs. 29.8%; p=0.0004; OR: 0.35; 95% CI: 0.19-0.64). The median survival time after the first BM diagnosis was 4 months, and there was no significant difference in the survival periods for the various histological subtypes.
Conclusion: Adenocarcinoma and squamous cell were significantly associated with higher and lower risks of developing BM, respectively.
Keywords: Bone metastasis; Histology; Lung cancer; SRE.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer.Support Care Cancer. 2016 Feb;24(2):731-736. doi: 10.1007/s00520-015-2835-1. Epub 2015 Jul 5. Support Care Cancer. 2016. PMID: 26143039
-
Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.Tumour Biol. 2016 Jan;37(1):1131-40. doi: 10.1007/s13277-015-3907-z. Epub 2015 Aug 15. Tumour Biol. 2016. PMID: 26276360
-
Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer.BMC Cancer. 2019 Mar 15;19(1):238. doi: 10.1186/s12885-019-5445-3. BMC Cancer. 2019. PMID: 30876473 Free PMC article.
-
Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates.Lung Cancer. 2010 Jan;67(1):4-11. doi: 10.1016/j.lungcan.2009.08.020. Lung Cancer. 2010. PMID: 19939491 Review.
-
Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysis.Cancer Treat Rev. 2021 Mar;94:102168. doi: 10.1016/j.ctrv.2021.102168. Epub 2021 Feb 19. Cancer Treat Rev. 2021. PMID: 33730627
Cited by
-
Risk factor analysis of bone metastasis in patients with non-small cell lung cancer.Am J Transl Res. 2022 Sep 15;14(9):6696-6702. eCollection 2022. Am J Transl Res. 2022. PMID: 36247263 Free PMC article.
-
Differentiation of Bone Metastasis in Elderly Patients With Lung Adenocarcinoma Using Multiple Machine Learning Algorithms.Cancer Control. 2023 Jan-Dec;30:10732748231167958. doi: 10.1177/10732748231167958. Cancer Control. 2023. PMID: 37010850 Free PMC article.
-
Risk factors of bone metastasis in lung adenocarcinoma.BMC Pulm Med. 2025 Jul 2;25(1):299. doi: 10.1186/s12890-025-03702-0. BMC Pulm Med. 2025. PMID: 40604601 Free PMC article.
-
The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.J Cancer Res Clin Oncol. 2020 Nov;146(11):2731-2741. doi: 10.1007/s00432-020-03379-4. Epub 2020 Sep 5. J Cancer Res Clin Oncol. 2020. PMID: 32892231 Free PMC article. Review.
-
Bone Metastases Pattern in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Real-World Analysis in the SEER Database.Biomed Res Int. 2020 Jul 16;2020:2098325. doi: 10.1155/2020/2098325. eCollection 2020. Biomed Res Int. 2020. PMID: 32724795 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical